COPD 和哮喘設備市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

市場概覽

• COPD 和哮喘設備的全球市場規模到 2022 年將達到 434 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 604 億美元，顯示 2023 年至 2028 年的增長率 (CAGR) 為 5.31%。
• 慢性阻塞性肺病 (COPD) 是一種炎症性疾病，會損害肺部的氣流。 最初的症狀包括呼吸急促、喘息、胸悶、伴有或不伴有粘液的慢性咳嗽、經常感冒和喉嚨痛。 另一方面，哮喘，也稱為支氣管哮喘，是一種影響肺部氣道的呼吸系統疾病。 其症狀包括呼吸急促、胸悶、睡眠障礙、咳嗽和喘息發作。 用於施用吸入藥物的各種裝置用於治療這些呼吸系統疾病。 COPD 和哮喘機器，也稱為肺部給藥裝置，被用作呼吸系統疾病的永久性或補救性治療。 因此，我們在全世界獲得了巨大的支持。

COPD 和哮喘設備的市場趨勢

• 易患慢性呼吸道疾病的老年人口不斷增加是對市場產生積極影響的關鍵因素之一。 此外，吸煙人數的增加和單獨呼吸系統疾病的發病率正在增加 COPD 和哮喘設備的銷量。 除此之外，醫療保健支出的增加和醫療保健行業的持續自動化正在促進市場的增長。 先進醫療解決方案的激增為全球製造商提供了有利可圖的增長機會。 醫療保健和肺科專家現在更喜歡使用藥物和設備的組合來獲得快速有效的結果。 此外，化學工業的擴張增加了環境污染水平和呼吸問題，這推動了市場。 此外，便攜式給藥裝置的推出正在推動市場增長。

主要市場細分

• IMARC Group 分析了全球 COPD 和哮喘設備市場報告每個子部分的主要趨勢，並預測了 2023 年至 2028 年在全球、區域和國家層面的情況。 該報告根據產品、適應症和分銷渠道對市場進行分類。

按產品細分

• 吸入器
• 藥粉吸入器 (DPI)
• 中劑量吸入器 (MDI)
• 軟霧吸入器
• 霧化器
• 壓縮機霧化器
• 超聲波霧化器
• 網狀霧化器

按功效細分

• 支氣管哮喘
• 慢性阻塞性肺病

按銷售渠道細分

• 零售藥房
• 醫院
• 在線藥店

按地區劃分

• 北美
• 美國
• 加拿大
• 亞太地區
• 中國
• 日本
• 印度
• 韓國
• 澳大利亞
• 印度尼西亞
• 其他
• 歐洲
• 德國
• 法國
• 英國
• 意大利
• 西班牙
• 俄羅斯
• 其他
• 拉丁美洲
• 巴西
• 墨西哥
• 其他
• 中東和非洲

本報告中回答的關鍵問題

• 全球 COPD 和哮喘設備市場迄今為止的表現如何，未來幾年將如何表現？
• COVID-19 對全球 COPD 和哮喘設備市場有何影響？
• 主要的區域市場是什麼？
• 基於產品的市場細分是什麼？
• 基於指示的市場細分是什麼？
• 基於銷售渠道的市場細分是什麼？
• 行業價值鏈中有哪些不同階段？
• 該行業的主要驅動因素和挑戰是什麼？
• 全球 COPD 和哮喘治療市場的結構和主要參與者是什麼？
• 該行業的競爭程度如何？

內容

第一章前言

第 2 章研究方法和範圍

• 調查的目的
• 利益相關者
• 數據源
  • 主要信息
  • 次要信息
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章執行摘要

第四章介紹

• 概覽
• 主要行業趨勢

第 5 章 COPD 和哮喘設備的全球市場

• 市場概覽
• 市場結果
• COVID-19 的影響
• 市場預測

第 6 章按產品劃分的市場細分

• 吸入器
  • 市場趨勢
  • 主要細分市場
    • 藥粉吸入器 (DPI)
    • 中劑量吸入器 (MDI)
    • 軟霧吸入器
  • 市場預測
• 霧化器
  • 市場趨勢
  • 主要細分市場
    • 壓縮機式霧化器
    • 超聲波霧化器
    • 網狀霧化器
  • 市場預測

第 7 章按適應症劃分的市場細分

• 支氣管哮喘
  • 市場趨勢
  • 市場預測
• 慢性阻塞性肺病
  • 市場趨勢
  • 市場預測

第 8 章分銷渠道市場細分

• 零售藥房
  • 市場趨勢
  • 市場預測
• 醫院
  • 市場趨勢
  • 市場預測
• 在線藥店
  • 市場趨勢
  • 市場預測

第 9 章按區域劃分的市場細分

• 北美
  • 美國
    • 市場趨勢
    • 市場預測
  • 加拿大
    • 市場趨勢
    • 市場展望
• 亞太地區
  • 中國
    • 市場趨勢
    • 市場展望
  • 日本
    • 市場趨勢
    • 市場預測
  • 印度
    • 市場趨勢
    • 市場展望
  • 韓國市場
    • 市場趨勢
    • 市場展望
  • 澳大利亞
    • 市場趨勢
    • 市場展望
  • 印度尼西亞
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 歐洲
  • 德國
    • 市場趨勢
    • 市場展望
  • 法國
    • 市場趨勢
    • 市場預測
  • 英國
    • 市場趨勢
    • 市場預測
  • 意大利
    • 市場趨勢
    • 市場展望
  • 西班牙
    • 市場趨勢
    • 市場展望
  • 俄羅斯
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 拉丁美洲
  • 巴西
    • 市場趨勢
    • 市場展望
  • 墨西哥
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測
• 中東和非洲
  • 市場趨勢
  • 按國家/地區劃分的市場細分
  • 市場展望

第 10 章 SWOT 分析

• 概覽
• 強度
• 弱點
• 機會
• 威脅

第11章價值鏈分析

第12章搬運工五力分析

• 概覽
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第 13 章：價格分析

第14章競爭格局

• 市場結構
• 主要公司
• 主要公司簡介
  • Adherium Limited
  • Aristopharma Ltd.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Cohero Health Inc.
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Pari Respiratory Equipment Inc.
  • Recipharm AB
  • Verona Pharma plc

Market Overview:

• The global COPD and asthma devices market size reached US$ 43.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 60.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028.
• Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

• The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

• IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

• Inhalers
• Drug Powdered Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• Soft Mist Inhalers
• Nebulizers
• Compressor Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers

Breakup by Indication:

• Asthma
• COPD

Breakup by Distribution Channel:

• Retail Pharmacies
• Hospitals
• Online Pharmacies

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

• The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report:

• How has the global COPD and asthma devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global COPD and asthma devices market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the indication?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global COPD and asthma devices market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Inhalers
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Drug Powdered Inhalers (DPIs)
    • 6.1.2.2 Metered Dose Inhalers (MDIs)
    • 6.1.2.3 Soft Mist Inhalers
  • 6.1.3 Market Forecast
• 6.2 Nebulizers
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Compressor Nebulizers
    • 6.2.2.2 Ultrasonic Nebulizers
    • 6.2.2.3 Mesh Nebulizers
  • 6.2.3 Market Forecast

7 Market Breakup by Indication

• 7.1 Asthma
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 COPD
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Retail Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Adherium Limited
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Aristopharma Ltd.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 AstraZeneca PLC
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Baxter International Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Boehringer Ingelheim International GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Cohero Health Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Koninklijke Philips N.V.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Omron Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Pari Respiratory Equipment Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Recipharm AB
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Verona Pharma plc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis

List of Figures

• Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
• Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2017-2022
• Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
• Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2022
• Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2022
• Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2022
• Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2022
• Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
• Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2022
• Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
• Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
• Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2022 and 2028
• Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2023-2028
• Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2023-2028
• Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
• Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
• Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
• Table 7: Global: COPD and Asthma Devices Market: Key Players